LysoPE(18:1/0:0)
|
Basic information |
| Metabolite name | LysoPE(18:1/0:0) |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | NA |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | LysoPE(18:1/0:0) |
| N/A |
|
N/A |
|
N/A |
| Synonyms | NA |
| No. of studies | 3 |
|
Relationship between LysoPE(18:1/0:0) and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1024 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
| Study M582 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6N mouse | Down |
| Study M582 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hippocampus | C57BL/6N mouse | Up |
| Study M582 | Type3 | control + fluoxetine group vs. control group | Hippocampus | C57BL/6N mouse | Up |
| Study M972 | Type1 | CRS + irradiation group vs. control group | Cerebral cortex | Sprague-Dawley rat | Up |